Clinical trial
Tiotropium (Spiriva) Rehabilitation Study
NCT00274521 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00274521 |
|---|---|
| Title | Tiotropium (Spiriva) Rehabilitation Study |
| Official title | A Randomized, Double-blind, Placebo Controlled 25-week Trial to Compare the Effect of Tiotropium Inhalation Capsuled (18 Mcg) Once Daily on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 8 Weeks of Pulmonary Rehabilitation. |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | Tiotropium |
| Enrollment | 108 |
| Start date | May 1, 2001 |
| Primary completion | Feb 1, 2003 |
| First posted | Jan 11, 2006 |
| Last update posted | Nov 1, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: